Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group
  • Chinese Optics Letters
  • Vol. 8,
  • Issue 4,
  • pp. 357-360
  • (2010)

Biocompatible and stable core/shell drug nanocarrier with high surface-enhanced Raman scattering activity

Not Accessible

Your library or personal account may give you access

Abstract

A novel drug carrier based on SiO2-coated silver nanoparticle aggregates and antitumor drug is successfully synthesized. The surface-enhanced Raman scattering (SERS) spectra of the antitumor drug in living cells are obtained. By using silver nano-aggregates as SERS substrates instead of dispersed silver particles, a great improvement of SERS signal intensity is achieved. It is found that the chemical stability of the drug carrier can also be increased with the existence of SiO2 shell. The adsorbing effect between antitumor drug 9-aminoacridine (9AA) and silver particles is investigated to optimize the SERS signal. The core/shell structure of the drug carrier is characterized by ultraviolet-visible (UV-Vis) spectroscopy and transmission electron microscopy (TEM) pictures. The experimental results show that the drug carrier offers biocompatibility, stability, and high SERS activity, holding the potential for realizing the intracellular drug tracing.

© 2010 Chinese Optics Letters

PDF Article
More Like This
Facile synthesis of metal-phenolic-coated gold nanocuboids for surface-enhanced Raman scattering

Mengfei Zhou, Chunxue Zhao, Yang Li, Yanxian Guo, Hao Liu, Yanling Zhang, and Zhiming Liu
Appl. Opt. 59(20) 6124-6130 (2020)

Colorimetric and SERS dual-mode detection of lead Ions based on Au-Ag core-shell nanospheres: featuring quick screening with ultra-high sensitivity

Zheng Zhang, Pei Ma, Junying Li, Yu Sun, Hao Shi, Nan Chen, Xuedian Zhang, and Hui Chen
Opt. Express 27(20) 29248-29260 (2019)

Cited By

You do not have subscription access to this journal. Cited by links are available to subscribers only. You may subscribe either as an Optica member, or as an authorized user of your institution.

Contact your librarian or system administrator
or
Login to access Optica Member Subscription

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.